Loading…

Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals

Introduction: Clostridioides difficile is a major pathogen responsible for hospital-associated diarrhoea. This study investigated the molecular epidemiology and antibiotic resistance of C. difficile isolates in five Algerian hospitals. Methodology: Between 2016 and 2019, faecal specimens were collec...

Full description

Saved in:
Bibliographic Details
Published in:Journal of infection in developing countries 2022-06, Vol.16 (6), p.1055-1063
Main Authors: Boudjelal, Youcef, Krutova, Marcela, Djebbar, Abla, Sebaihia, Mohammed, Bekara, Mohammed El Amine, Rouabhia, Samir, Couturier, Jeanne, Syed-Zaidi, Rabab, Barbut, Frédéric
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c222t-86ca54928869f2f4f75cbebd873e489d39146cda7139c9e321bc3c9cb8b56db93
cites
container_end_page 1063
container_issue 6
container_start_page 1055
container_title Journal of infection in developing countries
container_volume 16
creator Boudjelal, Youcef
Krutova, Marcela
Djebbar, Abla
Sebaihia, Mohammed
Bekara, Mohammed El Amine
Rouabhia, Samir
Couturier, Jeanne
Syed-Zaidi, Rabab
Barbut, Frédéric
description Introduction: Clostridioides difficile is a major pathogen responsible for hospital-associated diarrhoea. This study investigated the molecular epidemiology and antibiotic resistance of C. difficile isolates in five Algerian hospitals. Methodology: Between 2016 and 2019, faecal specimens were collected from in-patients and were cultured for C. difficile. Isolates were characterised by toxin genes detection, Polymerase Chain Reaction (PCR)-ribotyping, Multilocus Sequence Typing (MLST), antimicrobial susceptibility testing against a panel of antibiotics, and screened for antimicrobial resistance genes. Results: Out of 300 patient stools tested, 18 (6%) were positive for C. difficile by culture, and were found to belong to 11 different ribotypes (RT) and 12 sequence types (ST): RT 085/ST39, FR 248/ST259, FR 111/ST48, RT 017/ST37, RT 014/ST2, RT 014/ST14, FR 247/new ST, RT 005/ST6, RT 029/ST16, RT 039/ST26, RT 056/ST34 and RT 446/ST58. MLST analysis assigned the isolates to two clades, 1 and 4. Clade 4 was more homogeneous, as it mainly included non-toxigenic isolates. Three toxin gene profiles were detected, two toxigenic, A+B+CDT- (33.3%) and A-B+CDT- (11%); and one non-toxigenic, A-B-CDT- (55.5%). All C. difficile isolates were susceptible to metronidazole, vancomycin and moxifloxacin. Conclusions: Overall prevalence of C. difficile in our healthcare settings was 6%. Antibiotic resistance rates ranged from 72.2% (clindamycin) to 16.6% (tetracycline). This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patterns, in the C. difficile isolates. Further larger studies are needed to assess the true extent of C. difficile infections in Algeria.
doi_str_mv 10.3855/jidc.16056
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2686057375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2686057375</sourcerecordid><originalsourceid>FETCH-LOGICAL-c222t-86ca54928869f2f4f75cbebd873e489d39146cda7139c9e321bc3c9cb8b56db93</originalsourceid><addsrcrecordid>eNpdkU9LxDAQxYMouK5e_AQBLyJUm6Rpk-Oy-A9WvOi5pEm6zpJtapIi--3Nuh7Ew_CG4TfD8B5Cl6S8ZYLzuw0YfUvqktdHaEZkQwtai_L4T3-KzmLclCWXjJMZ-nrxzurJqYDtCMZuwTu_3mE1mFwJtqCD70A5HGyEmNSgLR5VSjYMEfseL52PKYABn7cjNtD3oMFZDNE7lfIIBrxwaxtADfjDxxGScvEcnfRZ7MWvztH7w_3b8qlYvT4-LxerQlNKUyFqrXglqRC17Glf9Q3Xne2MaJithDRMkqrWRjWESS0to6TTTEvdiY7XppNsjq4Pd8fgPycbU7uFqK1zarB-im22JLvVsIZn9OofuvFTGPJ3e0pyIQQpM3VzoLIvMQbbt2OArQq7lpTtPoN2n0H7kwH7Bh6HfNY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2689588810</pqid></control><display><type>article</type><title>Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals</title><source>Publicly Available Content Database</source><creator>Boudjelal, Youcef ; Krutova, Marcela ; Djebbar, Abla ; Sebaihia, Mohammed ; Bekara, Mohammed El Amine ; Rouabhia, Samir ; Couturier, Jeanne ; Syed-Zaidi, Rabab ; Barbut, Frédéric</creator><creatorcontrib>Boudjelal, Youcef ; Krutova, Marcela ; Djebbar, Abla ; Sebaihia, Mohammed ; Bekara, Mohammed El Amine ; Rouabhia, Samir ; Couturier, Jeanne ; Syed-Zaidi, Rabab ; Barbut, Frédéric</creatorcontrib><description>Introduction: Clostridioides difficile is a major pathogen responsible for hospital-associated diarrhoea. This study investigated the molecular epidemiology and antibiotic resistance of C. difficile isolates in five Algerian hospitals. Methodology: Between 2016 and 2019, faecal specimens were collected from in-patients and were cultured for C. difficile. Isolates were characterised by toxin genes detection, Polymerase Chain Reaction (PCR)-ribotyping, Multilocus Sequence Typing (MLST), antimicrobial susceptibility testing against a panel of antibiotics, and screened for antimicrobial resistance genes. Results: Out of 300 patient stools tested, 18 (6%) were positive for C. difficile by culture, and were found to belong to 11 different ribotypes (RT) and 12 sequence types (ST): RT 085/ST39, FR 248/ST259, FR 111/ST48, RT 017/ST37, RT 014/ST2, RT 014/ST14, FR 247/new ST, RT 005/ST6, RT 029/ST16, RT 039/ST26, RT 056/ST34 and RT 446/ST58. MLST analysis assigned the isolates to two clades, 1 and 4. Clade 4 was more homogeneous, as it mainly included non-toxigenic isolates. Three toxin gene profiles were detected, two toxigenic, A+B+CDT- (33.3%) and A-B+CDT- (11%); and one non-toxigenic, A-B-CDT- (55.5%). All C. difficile isolates were susceptible to metronidazole, vancomycin and moxifloxacin. Conclusions: Overall prevalence of C. difficile in our healthcare settings was 6%. Antibiotic resistance rates ranged from 72.2% (clindamycin) to 16.6% (tetracycline). This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patterns, in the C. difficile isolates. Further larger studies are needed to assess the true extent of C. difficile infections in Algeria.</description><identifier>ISSN: 1972-2680</identifier><identifier>ISSN: 2036-6590</identifier><identifier>EISSN: 1972-2680</identifier><identifier>DOI: 10.3855/jidc.16056</identifier><language>eng</language><publisher>Sassari: Journal of Infection in Developing Countries</publisher><subject>Antibiotics ; Antimicrobial agents ; Drug resistance ; Epidemiology</subject><ispartof>Journal of infection in developing countries, 2022-06, Vol.16 (6), p.1055-1063</ispartof><rights>2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c222t-86ca54928869f2f4f75cbebd873e489d39146cda7139c9e321bc3c9cb8b56db93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2689588810?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590</link.rule.ids></links><search><creatorcontrib>Boudjelal, Youcef</creatorcontrib><creatorcontrib>Krutova, Marcela</creatorcontrib><creatorcontrib>Djebbar, Abla</creatorcontrib><creatorcontrib>Sebaihia, Mohammed</creatorcontrib><creatorcontrib>Bekara, Mohammed El Amine</creatorcontrib><creatorcontrib>Rouabhia, Samir</creatorcontrib><creatorcontrib>Couturier, Jeanne</creatorcontrib><creatorcontrib>Syed-Zaidi, Rabab</creatorcontrib><creatorcontrib>Barbut, Frédéric</creatorcontrib><title>Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals</title><title>Journal of infection in developing countries</title><description>Introduction: Clostridioides difficile is a major pathogen responsible for hospital-associated diarrhoea. This study investigated the molecular epidemiology and antibiotic resistance of C. difficile isolates in five Algerian hospitals. Methodology: Between 2016 and 2019, faecal specimens were collected from in-patients and were cultured for C. difficile. Isolates were characterised by toxin genes detection, Polymerase Chain Reaction (PCR)-ribotyping, Multilocus Sequence Typing (MLST), antimicrobial susceptibility testing against a panel of antibiotics, and screened for antimicrobial resistance genes. Results: Out of 300 patient stools tested, 18 (6%) were positive for C. difficile by culture, and were found to belong to 11 different ribotypes (RT) and 12 sequence types (ST): RT 085/ST39, FR 248/ST259, FR 111/ST48, RT 017/ST37, RT 014/ST2, RT 014/ST14, FR 247/new ST, RT 005/ST6, RT 029/ST16, RT 039/ST26, RT 056/ST34 and RT 446/ST58. MLST analysis assigned the isolates to two clades, 1 and 4. Clade 4 was more homogeneous, as it mainly included non-toxigenic isolates. Three toxin gene profiles were detected, two toxigenic, A+B+CDT- (33.3%) and A-B+CDT- (11%); and one non-toxigenic, A-B-CDT- (55.5%). All C. difficile isolates were susceptible to metronidazole, vancomycin and moxifloxacin. Conclusions: Overall prevalence of C. difficile in our healthcare settings was 6%. Antibiotic resistance rates ranged from 72.2% (clindamycin) to 16.6% (tetracycline). This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patterns, in the C. difficile isolates. Further larger studies are needed to assess the true extent of C. difficile infections in Algeria.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Drug resistance</subject><subject>Epidemiology</subject><issn>1972-2680</issn><issn>2036-6590</issn><issn>1972-2680</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkU9LxDAQxYMouK5e_AQBLyJUm6Rpk-Oy-A9WvOi5pEm6zpJtapIi--3Nuh7Ew_CG4TfD8B5Cl6S8ZYLzuw0YfUvqktdHaEZkQwtai_L4T3-KzmLclCWXjJMZ-nrxzurJqYDtCMZuwTu_3mE1mFwJtqCD70A5HGyEmNSgLR5VSjYMEfseL52PKYABn7cjNtD3oMFZDNE7lfIIBrxwaxtADfjDxxGScvEcnfRZ7MWvztH7w_3b8qlYvT4-LxerQlNKUyFqrXglqRC17Glf9Q3Xne2MaJithDRMkqrWRjWESS0to6TTTEvdiY7XppNsjq4Pd8fgPycbU7uFqK1zarB-im22JLvVsIZn9OofuvFTGPJ3e0pyIQQpM3VzoLIvMQbbt2OArQq7lpTtPoN2n0H7kwH7Bh6HfNY</recordid><startdate>20220630</startdate><enddate>20220630</enddate><creator>Boudjelal, Youcef</creator><creator>Krutova, Marcela</creator><creator>Djebbar, Abla</creator><creator>Sebaihia, Mohammed</creator><creator>Bekara, Mohammed El Amine</creator><creator>Rouabhia, Samir</creator><creator>Couturier, Jeanne</creator><creator>Syed-Zaidi, Rabab</creator><creator>Barbut, Frédéric</creator><general>Journal of Infection in Developing Countries</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8C1</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20220630</creationdate><title>Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals</title><author>Boudjelal, Youcef ; Krutova, Marcela ; Djebbar, Abla ; Sebaihia, Mohammed ; Bekara, Mohammed El Amine ; Rouabhia, Samir ; Couturier, Jeanne ; Syed-Zaidi, Rabab ; Barbut, Frédéric</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c222t-86ca54928869f2f4f75cbebd873e489d39146cda7139c9e321bc3c9cb8b56db93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Drug resistance</topic><topic>Epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boudjelal, Youcef</creatorcontrib><creatorcontrib>Krutova, Marcela</creatorcontrib><creatorcontrib>Djebbar, Abla</creatorcontrib><creatorcontrib>Sebaihia, Mohammed</creatorcontrib><creatorcontrib>Bekara, Mohammed El Amine</creatorcontrib><creatorcontrib>Rouabhia, Samir</creatorcontrib><creatorcontrib>Couturier, Jeanne</creatorcontrib><creatorcontrib>Syed-Zaidi, Rabab</creatorcontrib><creatorcontrib>Barbut, Frédéric</creatorcontrib><collection>CrossRef</collection><collection>Public Health Database</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of infection in developing countries</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boudjelal, Youcef</au><au>Krutova, Marcela</au><au>Djebbar, Abla</au><au>Sebaihia, Mohammed</au><au>Bekara, Mohammed El Amine</au><au>Rouabhia, Samir</au><au>Couturier, Jeanne</au><au>Syed-Zaidi, Rabab</au><au>Barbut, Frédéric</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals</atitle><jtitle>Journal of infection in developing countries</jtitle><date>2022-06-30</date><risdate>2022</risdate><volume>16</volume><issue>6</issue><spage>1055</spage><epage>1063</epage><pages>1055-1063</pages><issn>1972-2680</issn><issn>2036-6590</issn><eissn>1972-2680</eissn><abstract>Introduction: Clostridioides difficile is a major pathogen responsible for hospital-associated diarrhoea. This study investigated the molecular epidemiology and antibiotic resistance of C. difficile isolates in five Algerian hospitals. Methodology: Between 2016 and 2019, faecal specimens were collected from in-patients and were cultured for C. difficile. Isolates were characterised by toxin genes detection, Polymerase Chain Reaction (PCR)-ribotyping, Multilocus Sequence Typing (MLST), antimicrobial susceptibility testing against a panel of antibiotics, and screened for antimicrobial resistance genes. Results: Out of 300 patient stools tested, 18 (6%) were positive for C. difficile by culture, and were found to belong to 11 different ribotypes (RT) and 12 sequence types (ST): RT 085/ST39, FR 248/ST259, FR 111/ST48, RT 017/ST37, RT 014/ST2, RT 014/ST14, FR 247/new ST, RT 005/ST6, RT 029/ST16, RT 039/ST26, RT 056/ST34 and RT 446/ST58. MLST analysis assigned the isolates to two clades, 1 and 4. Clade 4 was more homogeneous, as it mainly included non-toxigenic isolates. Three toxin gene profiles were detected, two toxigenic, A+B+CDT- (33.3%) and A-B+CDT- (11%); and one non-toxigenic, A-B-CDT- (55.5%). All C. difficile isolates were susceptible to metronidazole, vancomycin and moxifloxacin. Conclusions: Overall prevalence of C. difficile in our healthcare settings was 6%. Antibiotic resistance rates ranged from 72.2% (clindamycin) to 16.6% (tetracycline). This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patterns, in the C. difficile isolates. Further larger studies are needed to assess the true extent of C. difficile infections in Algeria.</abstract><cop>Sassari</cop><pub>Journal of Infection in Developing Countries</pub><doi>10.3855/jidc.16056</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1972-2680
ispartof Journal of infection in developing countries, 2022-06, Vol.16 (6), p.1055-1063
issn 1972-2680
2036-6590
1972-2680
language eng
recordid cdi_proquest_miscellaneous_2686057375
source Publicly Available Content Database
subjects Antibiotics
Antimicrobial agents
Drug resistance
Epidemiology
title Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A58%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20epidemiology%20and%20antimicrobial%20resistance%20patterns%20of%20Clostridioides%20difficile%20isolates%20in%20Algerian%20hospitals&rft.jtitle=Journal%20of%20infection%20in%20developing%20countries&rft.au=Boudjelal,%20Youcef&rft.date=2022-06-30&rft.volume=16&rft.issue=6&rft.spage=1055&rft.epage=1063&rft.pages=1055-1063&rft.issn=1972-2680&rft.eissn=1972-2680&rft_id=info:doi/10.3855/jidc.16056&rft_dat=%3Cproquest_cross%3E2686057375%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c222t-86ca54928869f2f4f75cbebd873e489d39146cda7139c9e321bc3c9cb8b56db93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2689588810&rft_id=info:pmid/&rfr_iscdi=true